Health
Argonne’s Advanced Photon Source guided the development of new COVID-19 vaccine now in trials – News-Medical.net
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two…
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory, and other light sources.
Trials are taking place at the Walter…
-
Business22 hours ago2 strong ASX ETFs to buy and hold forever
-
Business22 hours agoTop broker gives its verdict on Coles shares after 25% rise
-
Noosa News22 hours agoAndrew Burow: Link to alleged attacker uncovered in suspected murder of Kelvin Grove father
-
Business23 hours agoIs Nvidia’s increasing reliance on “Customer A” and “Customer B” a red flag for the AI growth stock?